CLINICAL STUDY: CARDIAC ARRHYTHMIAS
Detection and management of animplantable cardioverter defibrillator lead failure
Incidence and clinical implications
Kenneth A. Ellenbogen, MD, FACC*,*,
Mark A. Wood, MD, FACC*,
Richard K. Shepard, MD*,
Henry F. Clemo, MD, PhD, FACC*,
Tim Vaughn, BS ,
Keith Holloman, BA ,
Marlene Dow, RN ,
Jeanne Leffler, RN*,
Athula Abeyratne, PhD and
Dave Verness, BS, PE, CQE
* Division of Cardiology, Medical College of Virginia/Virginia Commonwealth University, Richmond, Virginia, USA
Medtronic, Inc., Minneapolis, Minnesota, USA
Manuscript received May 6, 2002;
revised manuscript received August 6, 2002,
accepted August 19, 2002.
* Reprint requests and correspondence: Dr. Kenneth A. Ellenbogen, Medical College of Virginia, P.O. Box 980053, Richmond, Virginia 23398-0053, USA. kellenbogen{at}pol.net
OBJECTIVES: This study evaluated the long-term reliability of an implantable cardioverter defibrillator (ICD) lead to determine the incidence, clinical presentation, and management of lead failure.
BACKGROUND: Despite recent advances in ICD technology, the long-term reliability of ICD leads remains a significant problem.
METHODS: Concern about long-term reliability of coaxial polyurethane ICD leads caused us to systematically study all patients implanted with Medtronic (Minneapolis, Minnesota) 6936 lead at our institution. We performed follow-up of 74 patients with 76 ICD leads that were implanted from February 28, 1995 to September 8, 1997. Thirty-seven patients underwent routine clinical ICD follow-up testing and ventricular fibrillation induction to determine the status of their ICD lead after a mean follow-up of 68.6 ± 8.2 months.
RESULTS: The lead survival analysis shows a cumulative failure probability of 37% (confidence interval, 24% to 54%) at 68.6 months. Six patients demonstrated a previously undescribed mode of ICD lead failure: prolonged oversensing immediately after shock therapy. The use of short interval counters to monitor nonphysiologic R-R intervals and the measurement of ring-to-coil impedance detected early lead failures in five patients.
CONCLUSIONS: This analysis shows: 1) problems with ICD leads may not become apparent until late during follow-up and may become a significant late problem, 2) a "signature" mode of lead failure for the 6936 consisting of oversensing of electrical noise following shocks, 3) early detection of lead failure with a short interval counter algorithm or measurement of ring-to-coil impedance may be clinically useful.
|
Abbreviations and Acronyms
| | CI | | confidence interval | | DFT | | defibrillation threshold | | ICD | | implantable cardioverter defibrillator | | MIO | | metal ion oxidation |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. T. Bennett, C. R. Kerr, E. Hahn, S. Flavelle, C. McIlroy, and S. K. K. Tung
Characteristics of patients and implantable defibrillators associated with failure to sense device alert systems
Europace,
November 1, 2010;
12(11):
1571 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Poole, M. J. Gleva, T. Mela, M. K. Chung, D. Z. Uslan, R. Borge, V. Gottipaty, T. Shinn, D. Dan, L. A. Feldman, et al.
Complication Rates Associated With Pacemaker or Implantable Cardioverter-Defibrillator Generator Replacements and Upgrade Procedures: Results From the REPLACE Registry
Circulation,
October 19, 2010;
122(16):
1553 - 1561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maytin, L. M. Epstein, and C. A. Henrikson
Lead Extraction Is Preferred for Lead Revisions and System Upgrades: When Less Is More
Circ Arrhythm Electrophysiol,
August 1, 2010;
3(4):
413 - 424.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Andrikopoulos, S. Tzeis, G. Theodorakis, and P. Vardas
Monitoring capabilities of cardiac rhythm management devices
Europace,
January 1, 2010;
12(1):
17 - 23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. W. Borleffs, L. van Erven, R. J. van Bommel, E. T. van der Velde, E. E. van der Wall, J. J. Bax, F. R. Rosendaal, and M. J. Schalij
Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads
Circ Arrhythm Electrophysiol,
August 1, 2009;
2(4):
411 - 416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Corrado, G. Gasparini, and A. Raviele
Lead malfunctions in implantable cardioverter defibrillators: where are we and where should we go?
Europace,
March 1, 2009;
11(3):
276 - 277.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kleemann and K. Seidl
Letter by Kleemann and Seidl Regarding Article, "Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term: Causes and Management"
Circulation,
January 6, 2009;
119(1):
e8 - e8.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goette, F. Cantu, L. van Erven, P. Geelen, F. Halimi, J. L. Merino, J. M. Morgan, and on behalf of the Scientific Initiative Committee o
Performance and survival of transvenous defibrillation leads: need for a European data registry
Europace,
January 1, 2009;
11(1):
31 - 34.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chinushi, Y. Hosaka, N. Ikarashi, K. Iijima, H. Furushima, and Y. Aizawa
Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture
Europace,
June 1, 2008;
10(6):
738 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Nielsen, H. Kottkamp, M. Zabel, E. Aliot, U. Kreutzer, A. Bauer, A. Schuchert, H. Neuser, B. Schumacher, H. Schmidinger, et al.
Automatic home monitoring of implantable cardioverter defibrillators
Europace,
June 1, 2008;
10(6):
729 - 735.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Maisel and D. B. Kramer
Implantable Cardioverter-Defibrillator Lead Performance
Circulation,
May 27, 2008;
117(21):
2721 - 2723.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Eckstein, M. T. Koller, M. Zabel, D. Kalusche, B. A. Schaer, S. Osswald, and C. Sticherling
Necessity for Surgical Revision of Defibrillator Leads Implanted Long-Term: Causes and Management
Circulation,
May 27, 2008;
117(21):
2727 - 2733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rozner
Management of Implanted Cardiac Defibrillators During Eye Surgery
Anesth. Analg.,
February 1, 2008;
106(2):
671 - 672.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rauwolf, M. Guenther, N. Hass, A. Schnabel, M. Bock, M.U. Braun, and R.H. Strasser
Ventricular oversensing in 518 patients with implanted cardiac defibrillators: incidence, complications, and solutions
Europace,
November 1, 2007;
9(11):
1041 - 1047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kleemann, T. Becker, K. Doenges, M. Vater, J. Senges, S. Schneider, W. Saggau, U. Weisse, and K. Seidl
Response to Letter Regarding Article, "Annual Rate of Transvenous Defibrillation Lead Defects in Cardioverter-Defibrillators Over a Period of >10 Years"
Circulation,
October 30, 2007;
116(18):
e513 - e513.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Ezekowitz, B. H. Rowe, D. M. Dryden, N. Hooton, B. Vandermeer, C. Spooner, and F. A. McAlister
Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction
Ann Intern Med,
August 21, 2007;
147(4):
251 - 262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. Maisel
Transvenous Implantable Cardioverter-Defibrillator Leads: The Weakest Link
Circulation,
May 15, 2007;
115(19):
2461 - 2463.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kleemann, T. Becker, K. Doenges, M. Vater, J. Senges, S. Schneider, W. Saggau, U. Weisse, and K. Seidl
Annual Rate of Transvenous Defibrillation Lead Defects in Implantable Cardioverter-Defibrillators Over a Period of >10 Years
Circulation,
May 15, 2007;
115(19):
2474 - 2480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vollmann, L. Luthje, and M. Zabel
Unusual cause for an increase of the sensing integrity counter in a patient with inappropriate implantable cardioverter-defibrillator therapy
Europace,
May 1, 2007;
9(5):
275 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Schoenfeld
Contemporary Pacemaker and Defibrillator Device Therapy: Challenges Confronting the General Cardiologist
Circulation,
February 6, 2007;
115(5):
638 - 653.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Occhetta, M. Bortnik, A. Magnani, G. Francalacci, and P. Marino
Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias
Europace,
October 1, 2006;
8(10):
863 - 869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol.,
September 5, 2006;
48(5):
e247 - e346.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace,
September 1, 2006;
8(9):
746 - 837.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vollmann, A. Erdogan, E. Himmrich, J. Neuzner, D. Becker, C. Unterberg-Buchwald, J. Sperzel, and for the SAFE Study Investigators
Patient AlertTM to detect ICD lead failure: efficacy, limitations, and implications for future algorithms.
Europace,
January 1, 2006;
8(5):
371 - 376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Senges-Becker, M. Klostermann, R. Becker, A. Bauer, K. E. Siegler, H. A. Katus, and W. Schoels
What is the "Optimal" follow-up schedule for ICD patients?
Europace,
January 1, 2005;
7(4):
319 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. D. Gunderson, A. S. Patel, C. A. Bounds, R. K. Shepard, M. A. Wood, and K. A. Ellenbogen
An algorithm to predict implantable cardioverter-defibrillator lead failure
J. Am. Coll. Cardiol.,
November 2, 2004;
44(9):
1898 - 1902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Becker, J. Ruf-Richter, J. C. Senges-Becker, A. Bauer, S. Weretka, F. Voss, H. A. Katus, and W. Schoels
Patient alert in implantable cardioverter defibrillators: toy or tool?
J. Am. Coll. Cardiol.,
July 7, 2004;
44(1):
95 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Roguin, C. S. Bomma, K. Nasir, H. Tandri, C. Tichnell, C. James, J. Rutberg, J. Crosson, P. J. Spevak, R. D. Berger, et al.
Implantable Cardioverter-Defibrillators in patients with arrhythmogenic right ventricular Dysplasia/Cardiomyopathy
J. Am. Coll. Cardiol.,
May 19, 2004;
43(10):
1843 - 1852.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Wichter, M. Paul, C. Wollmann, T. Acil, P. Gerdes, O. Ashraf, T. D.T. Tjan, R. Soeparwata, M. Block, M. Borggrefe, et al.
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients
Circulation,
March 30, 2004;
109(12):
1503 - 1508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Lead Failure Remains the Achilles' Heel of the ICD
Journal Watch Cardiology,
February 21, 2003;
2003(221):
2 - 2.
[Full Text]
|
 |
|
|